Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rajkumar

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
Haematologica|March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasoneRicardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
The Indian Journal of Tuberculosis|June 15, 2025
India's 2021 differentiated TB care guidance: Is it feasible to implement and act upon?Hemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Global Health, Science and Practice|April 28, 2023
The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care CascadeHemant Deepak Shewade, Asha Frederick, G Kiruthika, et al.
Global Health Action|January 9, 2023
--Eleven tips for operational researchers working with health programmes: our experience based on implementing differentiated tuberculosis care in south IndiaHemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
Haematologica|March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasoneRicardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Nature Reviews. Nephrology|December 5, 2018
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
Nature Reviews. Nephrology|December 21, 2018
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research GroupNelson Leung, Frank Bridoux, Vecihi Batuman, et al.
The Indian Journal of Tuberculosis|June 15, 2025
India's 2021 differentiated TB care guidance: Is it feasible to implement and act upon?Hemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Global Health, Science and Practice|April 28, 2023
The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care CascadeHemant Deepak Shewade, Asha Frederick, G Kiruthika, et al.
Global Health Action|January 9, 2023
--Eleven tips for operational researchers working with health programmes: our experience based on implementing differentiated tuberculosis care in south IndiaHemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, et al.
Pageof 20